Beyond traditional therapy: Mucoadhesive polymers as a new frontier in oral cancer management

Area of Science:

• Oncology
• Materials Science
• Pharmaceutical Sciences

Background:

• Oral cancer is a prevalent malignancy with challenging late-stage prognoses despite therapeutic advances.
• Targeted drug delivery systems are crucial for improving treatment efficacy and reducing side effects in oral cancer.
• Mucoadhesive polymers present a novel approach for localized drug delivery to oral tissues.

Purpose of the Study:

• To review current research on mucoadhesive polymers for drug delivery in oral cancer.
• To discuss the potential of mucoadhesive systems in improving oral cancer treatment outcomes.
• To highlight the adaptability and benefits of mucoadhesive polymers in various formulations.

Main Methods:

• Literature review of scientific research on mucoadhesive polymers and their application in oral cancer therapy.
• Analysis of studies focusing on mucoadhesive polymer formulations (tablets, films, gels, nanoparticles).
• Examination of research on enhanced bioavailability, tissue targeting, and reduced systemic toxicity.

Main Results:

• Mucoadhesive polymers can be formulated into diverse delivery systems like tablets, films, gels, and nanoparticles.
• These systems enhance drug bioavailability and enable targeted delivery to oral mucosa, improving drug distribution.
• Mucoadhesive strategies show potential in minimizing systemic side effects associated with conventional cancer therapies.

Conclusions:

• Mucoadhesive drug delivery systems are gaining traction as a viable and adaptable treatment strategy for oral cancer.
• These systems hold significant potential for improving the overall outcome of patients with late-stage oral cancer.
• Further research into mucoadhesive polymers can lead to advanced therapeutic options for oral malignancies.